Timothy Coughlin
Director · 4 filings · Latest: Jun 1, 2026
ADC Therapeutics SA
Travere Therapeutics, Inc.
aTYR PHARMA INC
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
ADCT | Timothy Coughlin | Director | Jun 3, 2026 | Tax Withholding | $3.08 | 12,600 | $38.8K | 72,400 | |
ADCT | Timothy Coughlin | Director | Jun 1, 2026 | Grant/Award | $0.00 | 45,000 | — | 85,000 | |
TVTX | Timothy Coughlin | Director | May 19, 2026 | Grant/Award | $0.00 | 4,000 | — | 56,250 | |
TVTX | Timothy Coughlin | Director | May 15, 2026 | Sale | $43.49 | 3,250 | $141.3K | 52,250 |